TABLE 2.
Groups | Baseline | Post-treatment | ||||
Non-paretic UL (μ V) | Paretic UL (μ V) | ASY | Non-paretic UL (μ V) | Paretic UL (μ V) | ASY | |
rTMS/sham SS | 3.84 (1.1 to 7.9) | 0.89 (0.7 to 5.5) | 3.04* | 2.46 (0.9 to 7.9) | 1.79 (0.7 to 6.1) | 0.76 |
sham rTMS/SS | 4.36 (1.8 to 8.4) | 0.89 (0.3 to 3.5) | 3.56* | 2.88 (1.7 to 8.4) | 1.21 (0.6 to 6.7) | 1.67 |
rTMS/SS | 2.88 (1.5 to 7.8) | 0.39 (0.1 to 4.9) | 2.58* | 2.16 (0.8 to 6.1) | 1.12 (0.2 to 6.8) | 1.04 |
sham rTMS/Sham SS | 5.53 (4 to 7.6) | 3.03 (0.5 to 4.4) | 2.53* | 4.53 (3.5 to 7.2) | 2.40 (0.1 to 3.4) | 2.13* |
ASY, interhemispheric asymmetry; SS, peripheral somatosensory stimulation; rTMS, repetitive transcranial magnetic stimulation; UL, upper limb. Data are presented median and interquartile range.
*p<0.05, Wilcoxon tests.